Skip to main content
. 2012 Oct 24;2:765. doi: 10.1038/srep00765

Table 1. Pilot Clinical Findings in Melanoma.

          Therapy
Signaturea TL-ELNs Sample No.a Tumor Location Time (in months)b None Surgery Chemoe XRT Other
+ + 112 Pancreas 180c,d     +   Ipi
+ + 115 Lung 114c,d   +      
+ + 116 Lung 72c,d   +   +  
+ + 113 Lung 72c   + +    
+ + 118 Pelvic soft tissue 65c +        
5 Liver 36     +    
1 Brain 35   +   +  
3 Brain 30   +   + IFN
6 Skinf 13   +      
7 Node 8 +        

aSee Figure 2c.

bTime (in months) since primary melanoma to death or present date of evaluation.

cp = 0.008 compared to signature − group (exact Wilcoxon rank sum test).

dAlive as of May 1, 2012.

eChemotherapy drugs included: carbo-taxol (1 patient), temozolomide (2 patients), liposomal cytarabine and sagopilone (1 patient each).

fSubcutaneous metastasis.

Abbreviations: Ipi, ipilimumab; IFN, interferon-alfa; XRT, external beam radiation therapy.